Special focus on cardiac toxicity from a pilot study of the adjuvant sequencing chemotherapy of doxorubicin/docetaxel/CMF regimen and radiotherapy with a mid-term follow-up in patients treated for poor prognosis breast cancer

C.Philippson; N.Magne′; A.Di Le′o; I.Veys; D.Larsimont; S.Simon; J.-M.Nogaret; M.J.Piccart; P.Van Houtte

首页> 外文期刊>European Journal of Cancer Supplements >Special focus on cardiac toxicity from a pilot study of the adjuvant sequencing chemotherapy of doxorubicin/docetaxel/CMF regimen and radiotherapy with a mid-term follow-up in patients treated for poor prognosis breast cancer

【24h】

Special focus on cardiac toxicity from a pilot study of the adjuvant sequencing chemotherapy of doxorubicin/docetaxel/CMF regimen and radiotherapy with a mid-term follow-up in patients treated for poor prognosis breast cancer

机译：对预后不良的乳腺癌患者进行的阿霉素/多西他赛/ CMF方案辅助化疗和放疗以及中期随访的初步研究特别关注心脏毒性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2004年第3期|共1页
作者
C.Philippson; N.Magne′; A.Di Le′o; I.Veys; D.Larsimont; S.Simon; J.-M.Nogaret; M.J.Piccart; P.Van Houtte;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patients. [J] . Magne N, Castadot P, Chargari C, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2009,第1期

机译：特别关注乳腺癌患者中不同顺序的阿霉素/多西他赛/ CMF辅助疗法联合放疗的心脏毒性。
2. Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen. [J] . Aksoy S, Harputluoglu H, Guler N, The breast journal . 2007,第4期

机译：吸烟史对乳腺癌预后的影响：回顾性研究240例接受辅助环磷酰胺，阿霉素和5-氟尿嘧啶化疗方案的可手术乳腺癌患者。
3. Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099. [J] . Alvarez RH, Booser DJ, Cristofanilli M, Cancer: A Journal of the American Cancer Society . 2010,第5期

机译：根据IIB期至III期乳腺癌患者的临床和病理反应，采用阿霉素和多西他赛进行初次全身治疗，然后进行手术，放疗和辅助化疗联合环磷酰胺，甲氨蝶呤和5-氟尿嘧啶的2期临床试验：德克萨斯大学医学博士安德森癌症中心研究ID97-099。
4. Brain cortical structural differences between non-central nervous system cancer patients treated with and without chemotherapy compared to non-cancer controls: a cross-sectional pilot MRI study using clinically-indicated scans [C] . Mark S. Shiroishi, Vikash Gupta, Bavrina Bigjahan, 13th international conference on medical information processing and analysis . 2017

机译：与非癌症对照组相比，接受和不接受化疗的非中枢神经系统癌症患者的大脑皮层结构差异：采用临床指征扫描的横断面MRI研究
5. Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide followed by adjuvant capecitabine/docetaxel vs docetaxel in patients with operable breast cancer [O] . Minmin Zhang, Wei Wei, Jianlun Liu, 2016

机译：在可手术乳腺癌患者中新辅助化疗方案卡培他滨/厄比霉素/环磷酰胺与5-氟尿嘧啶/厄比霉素/环磷酰胺再辅以卡培他滨/多西他赛与多西他赛的疗效和毒性比较
6. PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WITH DOCETAXEL FOR EARLY BREAST CANCER: COST-EFFECTIVENESS ANALYSIS (CEA) OF A DOCETAXEL, DOXORUBICIN AND CYCLOPHOSPHAMIDE REGIMEN (TAC) VERSUS 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN FRANCE [O] . Miadi-Fargier H, Le Pen C, Woronoff-Lemsi MC, 2005

机译：PCN12辅助化疗与DOCETAXEL对早期乳腺癌的影响：DOCETAXEL，阿霉素和环磷酰胺（TAC）与5-氟尿嘧啶，阿霉素，环磷酰胺和环磷酰胺的成本效益分析（CEA）

Special focus on cardiac toxicity from a pilot study of the adjuvant sequencing chemotherapy of doxorubicin/docetaxel/CMF regimen and radiotherapy with a mid-term follow-up in patients treated for poor prognosis breast cancer

著录项

相似文献

相关主题

期刊订阅